Related Experiment Video
Updated: Feb 15, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages
T C Edwards1, J Emerson2, A Genatossio2
1Department of Health Services, University of Washington, 1208 NE 43rd St. - Campus Box 359455, Seattle, WA 98195-9455, United States.
Insights
Observer-reported outcomes (ObsROs) are promising for young children with cystic fibrosis (CF). Parent-reported instruments showed good reliability for ages 0-6, suggesting potential for early intervention trials in pediatric CF patients.
Area of Science:
- Pediatric clinical trial methodology
- Respiratory medicine
- Patient-reported outcomes research
Background:
- Patient-reported outcomes (PROs) are crucial clinical trial endpoints.
- Young children often cannot reliably self-report, necessitating observer-reported outcomes (ObsROs).
- Cystic Fibrosis (CF) requires reliable outcome measures in pediatric populations.
Purpose of the Study:
- To develop and pilot electronic parent-reported observational instruments for children with CF aged 0-6 and 7-11 years.
- To assess the feasibility and preliminary psychometric properties of these instruments.
- To inform the development of appropriate endpoints for early intervention trials in young children with CF.
Main Methods:
- Concept elicitation interviews with parents of children with CF (≤11 years) to identify observable signs.
- Instrument refinement based on parent and clinician feedback.
- Pilot field testing to evaluate test-retest reliability and discriminative ability between well and sick states.
Main Results:
- Developed a 17-item observational instrument assessing respiratory signs and CF impacts.
- Achieved acceptable test-retest reliability for both age groups (0-6 and 7-11 years).
- Observed low discriminative ability for the 7-11 year age group, potentially due to decreased parental observation.
Conclusions:
- Parent-reported ObsROs show promise for children with CF aged 0-6 years.
- Self-report may be more suitable for children with CF older than 6 years.
- The 0-6 year instrument is a potential endpoint for early intervention clinical trials in pediatric CF, requiring further validation.
Purpose:
Patient-reported outcomes are important clinical trial endpoints. Young children may not be able to reliably report on how they feel or function, so observer-reported outcomes (ObsROs) may be more appropriate for them. The purpose of this study was to develop and pilot field test electronic parent-reported observational instruments for children with cystic fibrosis (CF) 0-6 and 7-11years of age.
Methods:
We performed concept elicitation interviews with parents of children with CF ≤11years of age to elicit the respiratory signs they could observe at baseline and during an acute respiratory illness. The resulting instruments were refined based on interviews with parents and clinicians. We conducted a pilot field test to evaluate test-retest reliability and the ability of items to distinguish well and sick periods.
Results:
The instruments consist of 17 items assessing respiratory signs and observable CF-related impacts. Test-retest reliability was acceptable for both age groups but discrimination was low for ages 7-11, likely reflecting less direct observation of older children by their parents.
Conclusions:
An ObsRO for children with CF ages 0-6 appears promising, while self-report may be more appropriate for children >6years of age. Next steps for the 0-6year old instrument will be utilizing it as an exploratory endpoint in clinical trials to enable item reduction, scale development, and further reliability and validity testing. Ultimately, this ObsRO could be a promising endpoint for early intervention trials in young children with CF.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Self-Report Tests of Personality
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Pilot and Numeric Relaying

